Lucid Diagnostics (LUCD) Common Equity (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Common Equity came in at $4.0 million in Q1 2026, up 174.39% YoY from $1.5 million in Q1 2025, and down 63.42% on a QoQ basis from $10.9 million in Q4 2025.
Lucid Diagnostics (LUCD) Common Equity (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Common Equity data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Common Equity rose 174.39% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 174.39% YoY) and the FY2025 annual result came in at $10.9 million, up 102.86% from the prior year.
- Common Equity retreated to $4.0 million in Q1 2026, from $10.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $46.5 million in Q1 2022 to a low of -$5.4 million in Q1 2025.
- A 5-year average of $15.1 million and a median of $11.9 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity jumped 384.07% — and 2025, when it tumbled 145.21%.
- Tracing LUCD's Common Equity over 5 years: stood at $23.0 million in 2022, then tumbled by 110.03% to -$2.3 million in 2023, then jumped by 333.28% to $5.4 million in 2024, then surged by 102.86% to $10.9 million in 2025, then plunged by 63.42% to $4.0 million in 2026.
- The last three Common Equity figures came in at $4.0 million (Q1 2026), $10.9 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 10.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.93 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 10.94 Mn |
| Sep 30, 2025 | 25.84 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | -5.38 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 6.34 Mn |
| Jun 30, 2024 | 15.98 Mn |
| Mar 31, 2024 | 11.89 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 15.07 Mn |
| Mar 31, 2023 | 24.91 Mn |
| Dec 31, 2022 | 23.05 Mn |
| Sep 30, 2022 | 27.53 Mn |
| Jun 30, 2022 | 36.24 Mn |
| Mar 31, 2022 | 46.49 Mn |
| Dec 31, 2021 | 54.74 Mn |
| Sep 30, 2021 | -24.13 Mn |